Pipeline of possible opportunities

XL TechGroup's pipeline includes unmet market needs that have been matched with technologies to create Complete Opportunities, from which the next new companies might be selected. It is however very important to note that, while XL TechGroup has exclusive rights to most of the technologies described, the nature of the rigorous XL TechGroup selection process means that only a few of these opportunities will ever be chosen for development and scaling as new companies by XL TechGroup. Some of the opportunities that do not fully meet XL TechGroup's selection criteria may be transferred to GenXL for further review and potential commercialisation. Furthermore, the pipeline is continuously evolving as new opportunities are added and as existing opportunities are eliminated.

The following list represents a snapshot of the current possibilities:

• a technology for the commercial scale production of unique proteins with revolutionary physical properties and multiple completely novel applications in industry, consumer products and healthcare;
• a designer micro-organism that efficiently produces isoprene, a direct replacement for gasoline and propane;
• a unique proprietary technology that provides a method for rapidly screening active ingredients for functional foods targeted at treating chronic metabolic disorders such as obesity and type 2 diabetes;
and
• an offshoot of a novel cancer vaccine technology which is adapted as a peripheral blood diagnostic to screen for early cancer detection.